Skip to main content
Screener/Healthcare/Biotechnology

ENTA — Enanta Pharmaceuticals, Inc.

NASDAQ
$12.59-0.41 (-3.12%)
Micro CapUnder $20Healthcare
$6.45
$17.15
$12.50
$12.99
EPS (TTM)$-2.74
P/E Ratio-4.10
Dividend Yield—
Market Cap$261.9M
Volume74K
Prev Close$13.00
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q2 '26$17.2M-$13.1M$-0.45-108.5%-76.3%
Q1 '26$18.6M-$11.9M$-0.56100.0%-64.1%
Q4 '25$15.1M-$18.7M$-0.87100.0%-123.6%
Q3 '25$18.3M-$18.3M$-0.86100.0%-99.7%
Q2 '25$14.9M-$22.6M$-1.06100.0%-151.7%
Q1 '25$17.0M-$22.3M$-1.05100.0%-131.4%
Q4 '24$14.6M-$28.8M$-1.36100.0%-197.3%
Q3 '24$18.0M-$22.7M$-1.07100.0%-126.1%
Get Your Daily Market Recap